AstraZeneca reported core earnings for the fourth quarter just short of consensus, but said it expected double-digit percentage growth in 2024.
Lawsuit by Humboldt Broncos’ families dismissed by judge | Globalnews.ca
December 24, 2025
7:25 pm
